Prognostic value of heart rate variability after acute myocardial infarction

Medical Science Monitor

Volumn 10, Issue 7, 2004, Pages

  Balanescu, Serban ^a,b   Corlan, Alexandru Dan ^b   Dorobantu, Maria ^a   Gherasim, Leonida ^b  

^a UNIVERSITY EMERGENCY HOSPITAL BUCHAREST   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Heart rate variability; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; GLYCERYL TRINITRATE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD CLOT LYSIS; CALCULATION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REPERFUSION; HEART RATE VARIABILITY; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PROGNOSIS; RISK ASSESSMENT; SUDDEN DEATH; SURVIVAL RATE; SURVIVAL TIME; SYMPATHETIC TONE; TRANSLUMINAL CORONARY ANGIOPLASTY; VAGUS TONE;

EID: 3342882698     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Volpi A, DeVita C, Franzosi M et al: Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation, 1993; 88: 416-29
2. Maggioni A, Zuanetti G, Franzosi M et al: Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation, 1993; 87: 312-22
3. Lown B, Verrier R: Neural activity and ventricular fibrillation. N Engl J Med, 1976; 294: 1165-70
4. Schwartz P, La Rovere M, Vanoli E: Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation, 1992; 85(Suppl.1): 177-91
5. Billman G, Schwartz P, Stone H: Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation, 1982; 66: 874-80
6. Schwartz P, Vanoli E, Stramba-Badiale M et al: Autonomic mechanisms and sudden death: new insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation, 1988; 78: 969-79
7. Schwartz P, Priori S: Sympathetic nervous system and cardiac arrhythmias. In: Zipes D, Jalife J, eds. Cardiac electrophysiology: from cell to bedside. Philadelphia: WB Saunders Co, 1990; 330-43
8. Kleiger R, Miller J, Bigger J, Moss A, and the Multicenter Post-Infarction Research Group: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol, 1987; 89: 256-62
9. Bigger J, Fleiss J, Steinman R et al: Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation, 1992; 85: 164-71
10. Hohnloser S, Klingenheben T, van de Loo A et al: Reflex versus tonic vagal activity as a prognostic parameter in patients with sustained ventricular tachycardia or ventricular fibrillation, Circulation, 1994; 89(3): 1068-73
11. La Rovere M, Mortara A, Schwartz P: Baroreflex sensitivity. J Cardiovasc Electrophysiol, 1995; 6: 761-74
12. Farrell T, Bashir Y, Cripps T et al: Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal averaged electrocardiogram. J Am Coll Cardiol, 1991; 18: 687-97
13. Fries R, Hein S, Konig J: Reversed circadian rhythms of heart rate variability and morning peak occurrence of sustained ventricular tachyarrhythmias in patients with implanted cardioverter defibrillator. Med Sci Monit, 2002; 8(11): CR751-CR756
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation and clinical use. Circulation, 1996; 93(5): 1043-63
15. Pepine C, Kem M, Boden W: Advisory Group Reports on silent myocardial ischemia, acute intervention after myocardial infarction and postinfarction management. Am J Cardiol, 1992; 69: 41B-46B
16. Algra A, Tijssen J, Roelandt J et al: Heart rate variability from 24-hour electrocardiography and the 2-year risk for sudden death. Circulation, 1993; 88(1): 180-85
17. Zuanetti G, Neilson J, Latini R et al: Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Circulation, 1996; 94: 432-36
18. La Rovere M, Bigger J, Marcus F et al: Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet, 1998; 351: 478-84
19. La Rovere M, Pinna G, Hohnloser S et al: Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias. Circulation, 2001; 103: 2072-77
20. Malik M, Camm A, Janse M et al: Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol, 2000; 35: 1263-75
21. Pedretti R, Colombo E, Sarzi Braga S, Caru B: Effect of thrombolysis on heart rate variability an d life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol, 1994; 23(1): 19-26
22. Hohnloser S, Franck P, Klingenheben T et al: Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era. A prospective trial. Circulation, 1994; 90(4): 1747-56
23. Lamas G, Flaker G, Mitchell G et al: Effect of infarct artery patency on prognosis after acute myocardial infarction. Circulation, 1993; 92: 1101-9
24. Singh N, Mironow D, Armstrong P et al for the GUSTO ECG Substudy Investigators: Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. Circulation, 1996; 93: 1388-95
25. Hermosillo A, Dorado M, Casanova J et al: Influence of infarct-related artery patency on the indexes of parasympathetic activity and prevalence of late potentials in survivors of acute myocardial infarction, J Am Coll Cardiol, 1993; 22(3): 695-706
26. Keeley E, Page R, Lange R et al: Influence of metoprolol on heart rate variability in survivors of remote myocardial infarction. Am J Cardiol, 1996; 77: 557-60
27. The GUSTO Investigators: An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med, 1995; 329: 673
28. Hohnloser S, Klingenheben T, Zabel M et al: Prevalence, characteristics and prognostic value during long term follow up of non sustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol, 1999; 33: 1895-902
29. Priori S, Aliot E, Blomstrom-Lundqvist C et al: Task Force on sudden cardiac death of the European Society of Cardiology. Eur Heart J, 2001; 22: 1374-450
30. La Rovere M, Bersano C, Gnemmi M et al: Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation, 2002; 106: 945-49
31. De Ferari G, Mantica M, Vanoli E et al: Scopolamine increases vagal tone and vagal reflexes in patients after myocardial infarction. J Am Coll Cardiol, 1993; 22(5): 1327-34
32. Vybiral T, Glaeser D, Morris G et al: Effects of low dose transdermal scopolamine on heart rate variability in acute myocardial infarction. J Am Coll Cardiol, 1993; 22(5): 1320-26
33. Pedretti R, Colombo E, Sarzi Braga S et al: Effects of oral pirenzepine on heart rate variability and baroreceptor sensitivity after acute myocardial infarction. J Am Coll Cardiol, 1995; 25: 915-21
34. Hull S, Vanoli E, Adamson P et al: Do increases in markers of vagal activity imply protection from sudden death? The case of scopolamine. Circulation, 1995; 91(10): 2516-19
35. Vanoli E, Cerati D, Pedretti R: Autonomic control of heart rate: pharmacological and nonpharmacological intervention. Basic Res Cardiol, 1998; 93(Suppl.1): 133-42
36. Statters D, Malik M, Redwood S et al: Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era. Am J Cardiol, 1996; 77: 133-38
37. Zeymer U, Senges J: Why do we need prospective registries in patients with acute myocardial infarction? Eur Heart J, 2003; 24: 1611-13
38. Zahn R, Schiele R, Gitt A et al: Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J, 2001; 142: 105